Status Quo of Chronic Liver Diseases, Including Hepatocellular Carcinoma, in Mongolia

por Jazag, Amarsanaa, Puntsagdulam, Natsagnyam, Chinburen, Jigjidsuren
Publicado 2012

The genomic landscape of Mongolian hepatocellular carcinoma

por Candia, Julián, Bayarsaikhan, Enkhjargal, Tandon, Mayank, Budhu, Anuradha, Forgues, Marshonna, Tovuu, Lkhagva-Ochir, Tudev, Undarmaa, Lack, Justin, Chao, Ann, Chinburen, Jigjidsuren, Wang, Xin Wei
Publicado 2020

Immunotherapy of liver cancer with hepcortespenlisimut-L: open-label Phase II clinical study in patients with advanced HCC

por Tarakanovskaya, Marina G, Chinburen, Jigjidsuren, Purevsuren, Genden, Munkhzaya, Chogsom, Batchuluun, Purev, Bat-Ireedui, Purev, Dandii, Dorjiin, Oyungerel, Dandii, Kutsyna, Galyna A, Bain, Allen I, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado 2015

Open-label Phase II clinical trial in 75 patients with advanced hepatocellular carcinoma receiving daily dose of tableted liver cancer vaccine, hepcortespenlisimut-L

por Tarakanovskaya, Marina G, Chinburen, Jigjidsuren, Batchuluun, Purev, Munkhzaya, Chogsom, Purevsuren, Genden, Dandii, Dorjiin, Hulan, Tsogkhuu, Oyungerel, Dandii, Kutsyna, Galyna A, Reid, Alan A, Borisova, Vika, Bain, Allen I, Jirathitikal, Vichai, Bourinbaiar, Aldar S
Publicado 2017